The full report suite on the U.S. market for neurological devices includes cerebrospinal fluid shunts, cerebrospinal fluid external drainage systems, intracranial pressure monitoring devices, detachable coils, liquid embolics, catheters, guidewires, balloon occlusion devices, neurovascular stents and flow diversion stents, spinal cord stimulators, vagus nerve stimulators, sacral nerve stimulators, deep brain stimulators, gastric electric stimulators, neuroendoscopes, stereotactic frames, stereotactic frameless systems, ultrasonic aspirators, aneurysm clips, neurosurgical microscopes, intrathecal pumps and mechanical thrombectomy devices.
Stereotaxy has become the standard of care in neurosurgery therefore the market for stereotactic systems is saturated, limiting growth in market value. Innovative technology and updated features and software will be required to encourage growth. New competitors have entered the neuromodulation market which will drive competitive pressure in technological advancement and pricing. This will have the greatest impact on the spinal cord stimulator and deep brain stimulator markets. One of the major market drivers for neurological devices is the patient and physicians demand for minimally invasive procedures. This has been driving the growth in interventional neuroradiology and neuroendoscopy. This has led to procedural growth in endovascular embolization treatments and a decline in aneurysm clipping procedures treatments. Access devices are becoming increasingly technologically advanced and various embolization devices have been released in recent years. One of the major emerging trends is the growth of mechanical thrombectomy devices for ischemic stroke. These devices extend the window for treatment of patients compared to medical therapy alone and can provide dramatically improved clinical outcomes.
'
TABLE OF CONTENTS I
LIST OF FIGURES X
LIST OF CHARTS XII
EXECUTIVE SUMMARY 1
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 8
MARKET DEVELOPMENTS 11
PROCEDURE NUMBERS 12
PROCEDURE CODES INVESTIGATED 13
MARKETS INCLUDED 15
KEY REPORT UPDATES 17
VERSION HISTORY 17
RESEARCH METHODOLOGY 18
1.1 RESEARCH SCOPE 18
1.2 IDATA’S 9-STEP METHODOLOGY 18
Step 1: Project Initiation & Team Selection 18
Step 2: Prepare Data Systems and Perform Secondary Research 20
Step 3: Preparation for Interviews & Questionnaire Design 21
Step 4: Performing Primary Research 22
Step 5: Research Analysis: Establishing Baseline Estimates 24
Step 6: Market Forecast and Analysis 25
Step 7: Identify Strategic Opportunities 27
Step 8: Final Review and Market Release 28
Step 9: Customer Feedback and Market Monitoring 29
DISEASE OVERVIEW 30
2.1 BASIC ANATOMY 30
2.2 DISEASE PATHOLOGY AND DISORDERS 32
2.2.1 Introduction 32
2.2.2 General Diagnostics and Neurosurgery 34
2.2.3 Tumor and Brain Cancer 36
2.2.4 Brain Arteriovenous Malformations 38
2.2.5 Ischemic Stroke 39
2.2.6 Brain Aneurysm 40
2.2.7 Disorders Related to Cerebrospinal Fluids and Intracranial Pressure 42
2.2.7.1 Hydrocephalus and Intracranial Pressure Disorder 42
2.2.7.2 Cerebral Edema 43
2.2.8 Indication for Neuromodulation 45
2.2.9 Traumatic brain injury 47
U.S. NEUROMODULATION, NEUROVASCULAR, NEUROSURGICAL AND MONITORING DEVICE MARKET OVERVIEW 48
3.1 INTRODUCTION 48
3.1.1 Cerebrospinal Fluid Management 48
3.1.2 Interventional Neuroradiology 49
3.1.3 Neuromodulation 49
3.1.4 Introduction to Neurosurgery 50
3.2 MARKET OVERVIEW 52
3.3 TREND ANALYSIS BY SEGMENT 59
3.4 DRIVERS AND LIMITERS 65
3.4.1 Market Drivers 65
3.4.1.1 Cerebrospinal Fluid Management 65
3.4.1.2 Interventional Neuroradiology 65
3.4.1.3 Neuromodulation 67
3.4.1.4 Neurosurgery 68
3.4.2 Market Limiters 69
3.4.2.1 Cerebrospinal Fluid Management 69
3.4.2.2 Interventional Neuroradiology 70
3.4.2.3 Neuromodulation 71
3.4.2.4 Neurosurgery 72
3.5 COMPETITIVE MARKET SHARE ANALYSIS 76
3.6 COMPANY PROFILES 87
3.6.1 B. Braun 87
3.6.2 Boston Scientific 88
3.6.3 BrainLab 91
3.6.4 Carl Zeiss 92
3.6.5 Codman & Shurtleff 93
3.6.6 Integra LifeScience 94
3.6.7 Leica Microsystems 95
3.6.8 LivaNova, PLC 96
3.6.9 Medtronic 97
3.6.10 MicroVention Terumo 99
3.6.11 Mizuho Co., Ltd. 100
3.6.12 St. Jude Medical 101
3.6.13 Stryker 102
3.6 MERGERS AND ACQUISITIONS 103
ABBREVIATIONS 107
APPENDIX II: COMPANY PRESS RELEASES 110
Chart 1 1: Neurological Device Market by Segment, U.S., 2013 – 2023 3
Chart 1 2: Neurological Device Market Overview, U.S., 2016 & 2023 3
Chart 3 1: Neurological Device Market by Segment, U.S., 2013 – 2023 57
Chart 3 2: Neurological Device Market Breakdown, U.S., 2016 58
Chart 3 3: Neurological Device Market Breakdown, U.S., 2023 58
Chart 3 4: Growth Rates by Segment, Neurological Device Market, U.S., 2013 – 2023 64
Chart 3 5: Leading Competitors, Neurological Device Market, U.S., 2016 86
Figure 1 1: Neurological Device Market Share Ranking by Segment, U.S., 2016 (1 of 3) 5
Figure 1 2: Neurological Device Market Share Ranking by Segment, U.S., 2016 (2 of 3) 5
Figure 1 3: Neurological Device Market Share Ranking by Segment, U.S., 2016 (3 of 3) 6
Figure 1 4: Companies Researched in this Report, U.S., 2016 7
Figure 1 5: Factors Impacting the Neurological Device Market by Segment, U.S. (1 of 3) 8
Figure 1 6: Factors Impacting the Neurological Device Market by Segment, U.S. (2 of 3) 9
Figure 1 7: Factors Impacting the Neurological Device Market by Segment, U.S. (3 of 3) 10
Figure 1 8: Recent Events in the Neurological Device Market, U.S., 2014 – 2016 11
Figure 1 9: Neurological Device Markets Covered, U.S., 2016 12
Figure 1 10: Procedural Codes Investigated, U.S., 2016 (1 of 2) 13
Figure 1 11: Procedural Codes Investigated, U.S., 2016 (2 of 2) 14
Figure 1 12: Neurological Device Markets Covered, U.S., 2016 (1 of 2) 15
Figure 1 13: Neurological Device Markets Covered, U.S., 2016 (2 of 2) 16
Figure 1 14: Key Report Updates 17
Figure 1 15: Version History 17
Figure 2 1: Neurology Disease Overview 33
Figure 2 2: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2016 37
Figure 3 1: Total Neurological Device Market, U.S., 2013 – 2023 (US$M) 53
Figure 3 2: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (1 of 3) 54
Figure 3 3: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (2 of 3) 55
Figure 3 4: Neurological Device Market by Segment, U.S., 2013 – 2023 (US$M) (3 of 3) 56
Figure 3 5: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (1 of 3) 61
Figure 3 6: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (2 of 3) 62
Figure 3 7: Neurological Device Market Growth by Segment, U.S., 2013 – 2023 (3 of 3) 63
Figure 3 8: Drivers and Limiters, Neurological Device Market, U.S., 2016 75
Figure 3 9: Leading Competitors, Neurological Device Market, U.S., 2016 (1 of 3) 83
Figure 3 10: Leading Competitors, Neurological Device Market, U.S., 2016 (2 of 3) 84
Figure 3 11: Leading Competitors, Neurological Device Market, U.S., 2016 (3 of 3) 85
Figure 5 1: Press Release Summary 110
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
